Pathophysiology and Treatment of Hepatitis C
- 1 January 1996
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 52 (2) , 1-8
- https://doi.org/10.2165/00003495-199600522-00003
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Response to interferon α therapy is influenced by the iron content of the liverJournal of Hepatology, 1994
- Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trialJournal of Hepatology, 1993
- Treatment of chronic hepatitis C with high-dose interferon ?-2bDigestive Diseases and Sciences, 1993
- Hepatitis C viremia and anti-HCV antibodies in alcoholicsJournal of Hepatology, 1992
- Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitisJournal of Hepatology, 1992
- Recombinant human interferon alfa-2a in community-acquired non-A, non-B chronic active hepatitis. Preliminary results of a randomized, controlled trialJournal of Hepatology, 1990
- A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitisJournal of Hepatology, 1990
- A randomized, double-blind, placebo-controlled trial of recombinant human α-interferon therapy for chronic non-A, non-B (type C) hepatitisJournal of Hepatology, 1990
- Prolonged treatment (18 months) of chronic hepatitis C with recombinant α-interferon in comparison with a control groupJournal of Hepatology, 1990
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989